Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics
Headquartered in Boston, Mass., Entrada is a private company that closed on its Series A in December 2018. To date, Entrada has raised over $50 million from 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund and Agent Capital.
At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platforms to yield treatments for patients in need.
Our Values
-
Humanity
We genuinely care about patients and about one another
-
Tenacity
We’re relentless and persistent in the pursuit of developing therapies for patients
-
Creativity
We’re creative problem solvers
-
Collaboration
We’re more than the sum of our parts
-
Curiosity
We’ve got a growth mindset
Join our team if you share our values, our devotion to science and our passion for helping patients.
-
What makes Entrada a great place to work is its high-energy environment, complemented by our employees’ shared desire to make a difference in science and on patients.
Leo Qian, Co-founder and Director, Discovery Research -
At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments.
Dipal Doshi, President and Chief Executive Officer
Current Openings
